Page last updated: 2024-11-13

fk1706

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

FK1706: non-immunosuppressive immunophilin ligand [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID58031837
SCHEMBL ID2742869
MeSH IDM0491689

Synonyms (2)

Synonym
SCHEMBL2742869
fk1706

Research Excerpts

Overview

FK1706 is a novel non-immunosuppressive immunophilin ligand with neurotrophic activity. It exerts its neurotrophic effect through NGF.

ExcerptReferenceRelevance
"FK1706 is a novel non-immunosuppressive immunophilin ligand with neurotrophic activity and exerts its neurotrophic effect through NGF. "( The Neurotrophic Effects and Mechanism of Action for FK1706 in Neurorrhaphy Rat Models and SH-SY5Y Cells.
Gao, W; Huang, W; Xu, L; Yang, H; Yang, Y, 2021
)
2.31

Treatment

ExcerptReferenceRelevance
"FK1706 treatment restored axon shape and staining patterns."( The effect of FK1706 on erectile function following bilateral cavernous nerve crush injury in a rat model.
Carrion, R; Hayashi, N; Lue, TF; Minor, TX; Nunes, L; Price, R, 2006
)
1.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]